ADAMSTUEN ZEBRAFISH LAB AS

Closed at February 29th, 2024

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board: AC
Ana Carolina Sulen Tavara1977
Operation time: 4 years; - Feb 12, 2020 to Feb 29, 2024
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 300,000; 1 share class
Total number of shareholders: 3; persons

Financials

Total equity 2022: 25,670; NOK

Last update: Jan 9, 2024

Management

Board

Name	Role	Shares
AC Ana Carolina Sulen Tavara 1977	Chairman	33.33 % directly
PJ Paul Johan Midtlyng 1953	Deputy Chair	33.33 % directly

Top 10 individual shareholders

Name	Role	Shares
PJ Paul Johan Midtlyng 1953	Deputy Chair	33.33 % directly
PC Peter Carl Gustaf Alestrøm 1951	-	33.33 % directly
AC Ana Carolina Sulen Tavara 1977	Chairman	33.33 % directly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
AC Ana Carolina Sulen Tavara 1977	Ordinary shares	100,000	33.33 %
PJ Paul Johan Midtlyng 1953	Ordinary shares	100,000	33.33 %
PC Peter Carl Gustaf Alestrøm 1951	Ordinary shares	100,000	33.33 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2022	2021
Total operating income	0	3,475
Annual Total Result	0	-492
Total assets	25,671	25,671
Total liabilities	0	-3,837
Total equity	25,670	29,508

P&L

Year	2022	2021
Total operating income	0	3,475
Total operating costs	0	3,967
Operating result	0	-492
Financial income/costs	0	0
Profit before tax	0	-492
Total tax & extraordinary income/cost	0	0
Annual Total Result	0	-492

Balance overview

Year	2022	2021
Total fixed assets	0	0
Total current assets	25,671	25,671
Total assets	25,671	25,671
Short term debt	0	-3,837
Long term debt	0	0
Total liabilities	0	-3,837
Contributed capital	30,000	30,000
Retained earnings	-4,330	-492
Total equity	25,670	29,508
Total equity and liabilities	25,670	25,671

ADAMSTUEN ZEBRAFISH LAB AS824 590 672